TCM

Tang Capital Management Portfolio holdings

AUM $1.98B
1-Year Est. Return 21.62%
This Quarter Est. Return
1 Year Est. Return
+21.62%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.81B
AUM Growth
+$296M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
208
New
Increased
Reduced
Closed

Top Buys

1 +$50.6M
2 +$45.2M
3 +$33.1M
4
SYRE icon
Spyre Therapeutics
SYRE
+$33.1M
5
SLRN
ACELYRIN
SLRN
+$24.3M

Top Sells

1 +$10.6M
2 +$7.23M
3 +$4.82M
4
ALMS
Alumis Inc
ALMS
+$4.72M
5
SEER icon
Seer Inc
SEER
+$1.52M

Sector Composition

1 Healthcare 94.79%
2 Technology 1.25%
3 Communication Services 1.23%
4 Consumer Discretionary 0.99%
5 Financials 0.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HPE icon
176
Hewlett Packard
HPE
$30B
$687K 0.04%
44,547
-1,844
CRBP icon
177
Corbus Pharmaceuticals
CRBP
$225M
$677K 0.04%
127,520
-115,133
KURA icon
178
Kura Oncology
KURA
$818M
$660K 0.04%
100,000
PBYI icon
179
Puma Biotechnology
PBYI
$260M
$592K 0.03%
200,000
ATXS icon
180
Astria Therapeutics
ATXS
$690M
$534K 0.03%
100,000
LXRX icon
181
Lexicon Pharmaceuticals
LXRX
$505M
$530K 0.03%
1,150,268
+300,000
PASG icon
182
Passage Bio
PASG
$25.8M
$530K 0.03%
75,000
OTLK icon
183
Outlook Therapeutics
OTLK
$57.7M
$488K 0.03%
400,000
+217,498
RVPH icon
184
Reviva Pharmaceuticals
RVPH
$41.7M
$487K 0.03%
510,329
+340,329
BCAB icon
185
BioAtla
BCAB
$38M
$477K 0.03%
1,374,076
ATRA icon
186
Atara Biotherapeutics
ATRA
$103M
$447K 0.02%
75,196
LAB icon
187
Standard BioTools
LAB
$508M
$440K 0.02%
407,755
IPSC icon
188
Century Therapeutics
IPSC
$48.3M
$428K 0.02%
900,000
AMLX icon
189
Amylyx Pharmaceuticals
AMLX
$1.54B
$354K 0.02%
100,000
SAVA icon
190
Cassava Sciences
SAVA
$177M
$300K 0.02%
+200,000
GRAL
191
GRAIL Inc
GRAL
$2.73B
$289K 0.02%
11,300
-188,700
KOD icon
192
Kodiak Sciences
KOD
$979M
$281K 0.02%
+100,000
MGNX icon
193
MacroGenics
MGNX
$121M
$278K 0.02%
218,856
QNCX icon
194
Quince Therapeutics
QNCX
$95.6M
$245K 0.01%
+184,383
IVVD icon
195
Invivyd
IVVD
$414M
$242K 0.01%
400,000
+69,828
NXTC icon
196
NextCure
NXTC
$24.6M
$194K 0.01%
33,679
-24,654
MGX icon
197
Metagenomi
MGX
$108M
$184K 0.01%
+134,978
JBIO
198
Jade Biosciences
JBIO
$441M
$175K 0.01%
+1,993
ATHA icon
199
Athira Pharma
ATHA
$15.2M
$171K 0.01%
600,000
MCRB icon
200
Seres Therapeutics
MCRB
$159M
$143K 0.01%
+10,195